Abrdn Life Sciences Investors HQL
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +9.89%
- 1 year
- +4.77%
- Open
- 18.77
- Prev close
- 18.74
- Mkt cap
- 560.72M
- Vol
- 86.55K
- Avg vol
- 133.35K
- EPS
- 6.64
- P/E
- 2.78
- Div yield
- 14.12%
More statistics
- Low
- 18.25
- High
- 18.77
- Forward P/E
- 0.00
- Beta
- 0.70
- Short ratio
- 0.41
- Inst. own
- 35.35%
- Dividend
- 2.00
- Ex-div date
- Nov 20, 2024
- 50-d avg
- 14.47
- 200-d avg
- 14.34
- 1y target
- 0.00
6M chart
Events in this range
- May 21, 2026Dividend: 0.56
- Aug 24, 2026Dividend: 0.62
Signals (25)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| RSI: Overbought | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 5 months ago |
Key statistics
- Market cap
- 377.99M
- Enterprise value
- 0
- Trailing P/E
- 4.43
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 107.60
- Price / book
- 0.84
- EPS (TTM)
- 3.04
- Beta
- 0.70
- Dividend yield
- 14.12%
- Payout ratio
- 54.61%
- Profit margin
- 156.45%
- Revenue (TTM)
- 3.51M
- Revenue growth
- 7.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 1.28%
- Shares outstanding
- 28.06M
- Short % of float
- 0.00%
- 50-day average
- 14.47
- 200-day average
- 14.34
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
Your note
Sign in to keep a note on HQL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DIMARTINO ROSE | Director | Purchase | Jul 15, 2024 | 1,000 |
| GOETZ KATHLEEN | Director | Purchase | Apr 8, 2024 | 1,085 |
| MAHER C WILLIAM | Director | Purchase | Aug 22, 2024 | 0 |
| OMSTEAD DANIEL R | President | Purchase | Sep 24, 2023 | 197,518 |
| REIT TODD | Director | Purchase | Jan 1, 2024 | 1,000 |
| SABA CAPITAL MANAGEMENT L P | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 25, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Saba Capital Management, L.P. | 12.54% | 3,429,991 | 46.20M | Sep 29, 2024 |
| Penserra Capital Management LLC | 2.84% | 776,002 | 10.45M | Sep 29, 2024 |
| Morgan Stanley | 1.79% | 489,687 | 6.60M | Sep 29, 2024 |
| Karpus Management, Inc. | 1.71% | 468,598 | 6.31M | Sep 29, 2024 |
| SIT Investment Associates Inc | 1.52% | 417,064 | 5.62M | Sep 29, 2024 |
| Needham Investment Management, L.L.C. | 1.29% | 352,719 | 4.75M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify High Income ETF | 2.83% | 774,198 | 10.43M | Sep 29, 2024 |
| Exchange Listed Fds Tr-Saba Closed-End Funds ETF | 0.98% | 268,088 | 3.61M | Aug 30, 2024 |
| Saba Capital Income & Opportunities Fund II | 0.47% | 128,601 | 1.73M | Jul 30, 2024 |
| AQR Funds-AQR Diversified Arbitrage Fd | 0.31% | 84,499 | 1.14M | Sep 29, 2024 |
| Saba Capital Income & Opportunities Fd | 0.14% | 37,835 | 509.64K | Jul 30, 2024 |
| First Trust Income Opportunity ETF | 0.05% | 13,358 | 179.93K | Oct 30, 2024 |